Fang Min, Edwards Robert J, Bartlet-Jones Michael, Taylor Graham W, Murray Stephen, Boobis Alan R
Section of Experimental Medicine and Toxicolog, Division of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 ONN, UK.
Carcinogenesis. 2004 Jun;25(6):1053-62. doi: 10.1093/carcin/bgh084. Epub 2004 Jan 23.
The food-derived, heterocyclic aromatic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is genotoxic and is carcinogenic in experimental animals. Studies on the role of PhIP in human diet-related cancer would be aided considerably by the availability of a readily applicable biomarker of the internal dose of the ultimate genotoxic species. PhIP has been shown to adduct primarily at C-8 of deoxyguanosine in DNA and so the DNA repair product N(2)-(2'-deoxyguanosin-8-yl)PhIP is a potential biomarker of DNA adduction and repair after exposure to PhIP. An assay for N(2)-(2'-deoxyguanosin-8-yl)PhIP in urine has been developed based on liquid chromatography mass spectrometry, using a deuterated analogue of the nucleoside as an internal standard and an antibody-mediated extraction procedure. Polyclonal antibodies were raised against the PhIP-nucleotide, PhIP-nucleoside and PhIP-guanine base adducts conjugated to keyhole limpet haemocyanin. Following their evaluation, the immobilized PhIP nucleotide antibody was used for the extraction of N(2)-(2'-deoxyguanosin-8-yl)PhIP from urine. The limit of detection of the assay was 125 pg and the limit of quantification 200 pg for a 50 ml human urine sample. Following oral administration of PhIP (20 mg/kg body wt/day) to rats for 6 days, N(2)-(2'-deoxyguanosin-8-yl) PhIP was readily detected in the urine, reaching steady state over 3 days. This is the first direct demonstration of the urinary elimination of this adduct following exposure to parent amine. The half-life of the adduct with DNA was estimated to be approximately 20 h. The total amount of PhIP recovered in the urine as adduct was <0.5 x 10(-3)% of the dose administered. Levels of the PhIP adduct in urine collections from human subjects ingesting the amine (4.9 micro g) in cooked meat were below the limits of detection, indicating that humans are exposed to a bioactive dose of <3 x 10(-4) of that associated with a non-carcinogenic level in rats.
食物来源的杂环芳香胺2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)具有遗传毒性,在实验动物中具有致癌性。如果能获得一种易于应用的终极遗传毒性物质体内剂量生物标志物,将极大地有助于研究PhIP在人类饮食相关癌症中的作用。PhIP已被证明主要在DNA中脱氧鸟苷的C-8位加成,因此DNA修复产物N(2)-(2'-脱氧鸟苷-8-基)PhIP是暴露于PhIP后DNA加成和修复的潜在生物标志物。基于液相色谱质谱法,使用核苷的氘代类似物作为内标和抗体介导的提取程序,开发了一种检测尿液中N(2)-(2'-脱氧鸟苷-8-基)PhIP的方法。制备了针对与钥孔血蓝蛋白偶联的PhIP-核苷酸、PhIP-核苷和PhIP-鸟嘌呤碱基加合物的多克隆抗体。经过评估后,固定化的PhIP核苷酸抗体用于从尿液中提取N(2)-(2'-脱氧鸟苷-8-基)PhIP。对于50 ml人尿液样本,该检测方法的检测限为125 pg,定量限为200 pg。给大鼠口服PhIP(20 mg/kg体重/天)6天,尿液中很容易检测到N(2)-(2'-脱氧鸟苷-8-基)PhIP,并在3天内达到稳态。这是首次直接证明暴露于母体胺后该加合物在尿液中的排泄情况。该加合物与DNA的半衰期估计约为20小时。尿液中作为加合物回收的PhIP总量<给药剂量的0.5×10(-3)%。摄入熟肉中该胺(4.9μg)的人类受试者尿液收集物中PhIP加合物水平低于检测限,表明人类接触的生物活性剂量<大鼠非致癌水平相关剂量的3×10(-4)。